Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check7 days agoChange DetectedRecruitment status on the study page now indicates no longer looking for participants. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label formatting plus the page revision to v3.6.0 (from v3.5.4) were updated.SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a small backend/format update; no visible changes to the study details are expected.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page shows a revision tag changing from v3.5.2 to v3.5.3, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check78 days agoChange DetectedHb SS disease added under Resources and Genetic and Rare Diseases Information Center listed as a Resources reference.SummaryDifference0.2%

- Check86 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.